share_log

BioCardia Q4 EPS $(0.09) Beats $(0.11) Estimate, Sales $13.00K Miss $90.00K Estimate

BioCardia Q4 EPS $(0.09) Beats $(0.11) Estimate, Sales $13.00K Miss $90.00K Estimate

BioCardia第四季度每股收益美元(0.09美元)超過預期(0.11美元),銷售額爲13.00萬美元,未達到90.00萬美元的預期
Benzinga ·  03/27 16:06

BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 43.75 percent increase over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $13.00 thousand which missed the analyst consensus estimate of $90.00 thousand by 85.56 percent. This is a 87.74 percent decrease over sales of $106.00 thousand the same period last year.

BioCardia(納斯達克股票代碼:BCDA)公佈的季度虧損爲每股0.09美元,比分析師普遍預期的0.11美元(0.11美元)高出18.18%。這比去年同期每股虧損0.16美元(0.16美元)增長了43.75%。該公司公佈的季度銷售額爲13,000美元,比分析師普遍預期的9萬美元低85.56%。這比去年同期的10.6萬美元的銷售額下降了87.74%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論